Tobacco the 'silent killer' of HIV patients, say researchers
Researchers at the University of York have shown that tobacco use is more common among HIV positive individuals than HIV negative individuals.
Jun 1, 2017
1
3
Researchers at the University of York have shown that tobacco use is more common among HIV positive individuals than HIV negative individuals.
Jun 1, 2017
1
3
The life expectancy of HIV-infected people in Europe and the United States has been boosted by a decade since anti-AIDS drugs became available in the mid-1990s, researchers said Thursday.
May 11, 2017
0
31
New data released today by the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe ahead of World TB Day show that new tuberculosis (TB) cases and deaths in the 53 countries of ...
Mar 20, 2017
0
0
(HealthDay)—Although progress has been made, blacks in America are still being hit harder by HIV/AIDS, a new report from the U.S. Centers for Disease Control and Prevention says.
Feb 3, 2017
0
3
Current methods to predict the risk of heart attack and stroke vastly underestimate the risk in individuals with HIV, which is nearly double that of the general population, reports a new Northwestern Medicine study.
Dec 21, 2016
0
2
Barriers to diagnosis and lack of access to modern medications have combined to place caregivers and HIV-positive patients in sub-Saharan Africa between a rock and a hard place. A new study shows that physicians are often ...
Dec 21, 2016
0
0
Antiretroviral drugs have been life-changing therapies for HIV patients, but they can have significant side effects.
Dec 16, 2016
0
9
While AIDS originally was seen as an adaptive immune disease, the research of Alan Landay, PhD, has contributed to a view of it as a cell driven-inflammation linked to immunosenescence—the gradual deterioration of the immune ...
Nov 30, 2016
0
0
HIV-1 associated nephropathy (HIVAN) is a kidney condition that can arise in HIV-positive patients of African ancestry who are not treated appropriately with antiretroviral therapy. Despite many years of extensive research, ...
Nov 3, 2016
0
0
(HealthDay)—The intravenous drug ibalizumab might revolutionize the treatment of HIV patients who don't respond to existing drugs, according to research presented at the annual meeting of the Infectious Diseases Society ...
Oct 29, 2016
0
0